← Open Payments lookup

JIMMY LEGROS: Open Payments

NPI 1063419745 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$657 in 27 payments from 10 companies in 2025. Trend: 2023 $266 · 2024 $124 · 2025 $657

Food & beverage: $657
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$203
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$158
ABBVIE INC.3$57
Otsuka America Pharmaceutical, Inc.3$57
Axsome Therapeutics, Inc.2$44
Vanda Pharmaceuticals Inc.2$44
Valinor Pharma, LLC3$44
Amgen Inc.1$19
GlaxoSmithKline, LLC.1$17
Supernus Pharmaceuticals, Inc.1$14

Products named: AIRSUPRA, CAPLYTA, VRAYLAR, REXULTI, Auvelity, FANAPT, MOVANTIK, BREZTRI.

Industry payments across LA — which companies pay providers there.